Background: There is currently no evidence of research priorities from nurses and allied health professionals working in the field of thoracic malignancies, which could provide strategic directions for funders, policy makers, and researchers. Objective: The aim of this study is to identify the priorities for lung cancer and other thoracic malignancies research and practice in nurses and allied health professionals. Methods: Descriptive cross-sectional web-based international survey conducted through international societies' membership lists. Results: Participants included 152 nurses and allied health professionals. Key priority categories were related to developing and evaluation interventions; symptom management interventions; health care system issues; treatment-related research (immunotherapy; targeted therapies); persistent/late effects management (fatigue; pulmonary toxicity); risk reduction, and screening research. The specific topic with the highest endorsement (80.9%) was the development of interventions to improve quality of life. Symptom management interventions, particularly for pain, dyspnea, and fatigue, were also highly endorsed. Health care system topics were related to delivery of care and included nurse-/allied health-led care (67.5%), working with the multidisciplinary team (67.5%), continuity of care (69.2%), and access to care (67.5%). Topics around screening/ early detection research were highly endorsed too. Conclusion: A clear focus (and need) for research in interventions to improve quality of life and symptom management, particularly for pain, dyspnea, and fatigue was also established, alongside healthcare system issues and screening research.
Control variables were age, sex, smoking status, cancer type, treatment received, marital status, and education. Results: Stress significantly decreased with time since diagnosis. IES-R scores, which decreased from 16.9 to 11.1, exhibited non-linearity as shown by increases in stress at 6 months, followed by decreases at approximately 12 months (see Figure 1). Interactions between time and cancer treatment were found non-significant, such that the observed trends in stress did not vary due to cancer treatment. For covariates, only education was significantly associated. Patients with a high school education or above had roughly 7-8 points lower mean IES-R scores (less stress) compared to patients with less than high school education. IES-R scores were not significantly associated with survival.
Conclusion:This is the first study to describe the course of stress for patients with advanced NSCLC as they received new cancer therapies. It is possible that more frequent assessments of the IES-R would have revealed significant associations with survival. Future research is needed in order to fully understand psychological risk factors for premature mortality from NSCLC.
evaluating nurse-led clinics. Nurse-led clinics have been in existence for years with little guidance on structure and evaluation. They are safe and effective. Nurses provide individual care that makes a difference to patient outcomes. There is vast evidence available for nurse-led services but significantly less on lung cancer specific services despite a growing body of evidence to support this. Methods: A literature search was performed. This included developing a lung cancer nurse-led clinic, evaluation, audit tool and measurement. The initial search found limited number of relevant documents. Therefore the search was widened to include developing general nurse-led services. The NLCFN members were surveyed to evaluate current nurse-led clinics. The questionnaire comprised of eighteen questions incorporating all aspects of nurse-led follow up.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.